UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

Journal of clinical oncology, 2001-07, Vol.19 (14), p.3312-3322

2001

Volltextzugriff (PDF)

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3056-3061

1996

Volltextzugriff (PDF)

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer

European journal of cancer (1990), 1997-07, Vol.33 (8), p.1216-1220

1997

Volltextzugriff (PDF)

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Annals of oncology, 2003-11, Vol.14 (11), p.1640-1647

2003

Volltextzugriff (PDF)

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

European journal of cancer (1990), 2003-03, Vol.39 (4), p.481-487

2003

Volltextzugriff (PDF)

Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: An EORTC Gynecological Cancer Cooperative Group study

Annals of oncology, 2001-07, Vol.12 (7), p.967-974

2001

Volltextzugriff (PDF)

Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study

Gynecologic oncology, 2001-06, Vol.81 (3), p.348-354

2001

Volltextzugriff (PDF)

Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factor

Mutagenesis, 2013-01, Vol.28 (1), p.39-48

2013

Volltextzugriff (PDF)

Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study

European journal of cancer (1990), 2001-09, Vol.37 (13), p.1624-1628

2001

Volltextzugriff (PDF)

The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer

The New England journal of medicine, 1995-03, Vol.332 (10), p.629-634

1995

Volltextzugriff (PDF)

Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding study

Breast cancer research and treatment, 2003-08, Vol.80 (3), p.257-265

2003

Volltextzugriff (PDF)

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003, Vol.39 (1), p.77-84

2003

Volltextzugriff (PDF)

Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1193-1202

2000

Volltextzugriff (PDF)

Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

Breast cancer research and treatment, 1999-11, Vol.58 (2), p.141-150

1999

Volltextzugriff (PDF)

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

Breast cancer research and treatment, 2000-07, Vol.62 (2), p.127-133

2000

Volltextzugriff (PDF)

D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study

Anti-cancer drugs, 2001-02, Vol.12 (2), p.159-162

2001

Volltextzugriff (PDF)

Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative Group

British journal of cancer, 1995-01, Vol.71 (1), p.106-108

1995

Volltextzugriff (PDF)

Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: A phase II study of the EORTC gynaecological cancer cooperative group (GCCG)

Gynecologic oncology, 1990-06, Vol.37 (3), p.359-362

1990

Volltextzugriff (PDF)

Phase II trial of epirubicin at standard dose in relapsed ovarian cancer

European journal of cancer (1990), 1996-05, Vol.32 (5), p.899-900

1996

Volltextzugriff (PDF)

Euthanasia: Less confusion from the professional point of view

Annals of oncology, 1993-11, Vol.4 (9), p.794-794

Lacave, A J

1993

Volltextzugriff (PDF)

Epithelial Ovarian Cancer: Rationale for Changing the One-Fits-All Standard Treatment Regimen to Subtype-Specific Treatment

International journal of gynecological cancer, 2014-03, Vol.24 (3), p.468-477

2014

Volltextzugriff (PDF)

The role of intervention debulking surgery in advanced epithelial ovarian cancer: an EORTC Gynecological Cancer Cooperative Group study

International journal of gynecological cancer, 1996-09, Vol.6 (Suppl 1), p.30-38

1996

Volltextzugriff (PDF)

Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer

Expert review of anticancer therapy, 2014-08, Vol.14 (8), p.887-900

2014

Volltextzugriff (PDF)

1 – 25 von 451

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(373)
Mit Volltextzugriff
(360)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(171)
Life Sciences & Biomedicine
(154)
Humans
(143)
Female
(104)
Middle Aged
(86)
Male
(81)
Adult
(77)
Aged
(73)
Biological And Medical Sciences
(73)
Oncology
(71)
Medical Sciences
(58)
Animals
(42)
Chemotherapy
(36)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Pharmacology. Drug Treatments
(35)
Antineoplastic Agents
(33)
Tumors
(23)
Rats
(22)
Survival Analysis
(20)
Treatment Outcome
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: An EORTC Gynecological Cancer Cooperative Group study

Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study

Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factor

Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study

The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer

Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding study

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group

Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study

Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative Group

Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: A phase II study of the EORTC gynaecological cancer cooperative group (GCCG)

Phase II trial of epirubicin at standard dose in relapsed ovarian cancer

Euthanasia: Less confusion from the professional point of view

Epithelial Ovarian Cancer: Rationale for Changing the One-Fits-All Standard Treatment Regimen to Subtype-Specific Treatment

The role of intervention debulking surgery in advanced epithelial ovarian cancer: an EORTC Gynecological Cancer Cooperative Group study

Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer

Suchergebnisse filtern